KRS Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
KRS Capital Management's LLY Position: Q2 2026 in Review
KRS Capital Management increased its Eli Lilly (LLY) stake by 0.13% in Q2 2026, buying an estimated $7.15K and bringing the position to 5,210 shares worth $6.25M. The position accounts for 2.91% of the portfolio, ranked #6.
KRS Capital Management first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- KRS Capital Management held 5,210 shares of Eli Lilly worth $6.25M as of Q2 2026.
- KRS Capital Management bought 7 Eli Lilly shares in Q2 2026, an estimated $7.15K.
- Eli Lilly made up 2.91% of KRS Capital Management's portfolio in Q2 2026, its #6 holding.
- KRS Capital Management first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
- 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on KRS Capital Management's 13F filing for Q2 2026, filed 20 Jul 2026.